Ligand validation:5CJT

B12: COBALAMIN

B12 is a Ligand Of Interest in 5CJT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5CJT_B12_A_1101	55%	51%	0.195	0.966	0.82	1.06	4	10	6	0	100%	1
5CJT_B12_B_1101	39%	53%	0.24	0.95	0.8	1	4	8	2	0	100%	1
5CJV_B12_A_1101	57%	51%	0.188	0.966	0.83	1.06	5	9	8	0	100%	1
4XC6_B12_A_1101	56%	50%	0.2	0.972	0.82	1.09	4	11	6	0	100%	1
5CJU_B12_A_1101	55%	51%	0.198	0.967	0.81	1.08	4	9	4	0	100%	1
5CJW_B12_B_1101	23%	53%	0.298	0.921	0.83	0.98	4	8	2	0	100%	1
3KQ4_B12_A_2007	100%	12%	0.04	0.996	1.51	2.55	10	38	4	1	100%	1
8IXU_B12_A_501	100%	63%	0.045	0.99	0.63	0.79	1	3	0	0	100%	1
4LEM_B12_A_601	99%	19%	0.051	0.98	1.29	2.13	8	34	0	0	100%	1
5D08_B12_A_503	99%	55%	0.054	0.983	0.72	1.01	3	10	0	0	100%	1
8IXT_B12_A_501	99%	60%	0.064	0.991	0.7	0.81	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.